NCT07568704 Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA Images
| NCT ID | NCT07568704 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intalight, Inc |
| Condition | Retina Pathology |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-03-25 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-03-25 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the image quality and clinical utility of the OCTA images from the VG200D OCT device (investigational device) compared against the FA and ICGA images from the UWF Optos California (CA) device. Image assessment will be conducted by three expert image graders and involve the assessment of the images based on both image quality and clinical utility. Evidence for substantial equivalence will be obtained through establishing similar image evaluation results across the devices based on image quality and clinical utility.
Eligibility Criteria
Inclusion Criteria: * Subjects 22 years of age or older on the date of informed consent * Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent * BCVA 20/400 or better in the study eye * Diagnosis of retinal associated pathology by investigator with the need to have an FA and/or ICGA performed in at least one eye Exclusion Criteria: * Subjects unable to tolerate ophthalmic imaging * Subjects not able to obtain acceptable OCT images due to ocular media opacity or other reasons * Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07568704 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Retina Pathology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07568704 currently recruiting?
Yes, NCT07568704 is actively recruiting participants. Contact the research team at mike.sinai@intalight.com for enrollment information.
Where is the NCT07568704 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07568704 clinical trial?
NCT07568704 is sponsored by Intalight, Inc. The trial plans to enroll 30 participants.